亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

深圳石金谷科技有限公司  

化學合成原料藥、醫藥中間體、化工原料、香精香料、食品輔料、植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:劉艷平
  • 電話:0755-61930350
  • 郵件:sz09@yccreate.com
  • 傳真:0755-84556470
  • QQ:2355880511
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 廠家直銷CAS號:161796-78-7埃索美拉唑鈉
廠家直銷CAS號:161796-78-7埃索美拉唑鈉
單價 面議對比
詢價 暫無
發貨 廣東深圳市付款后3天內
品牌 南箭
型號 161796-78-7
規格 醫藥級
過期 長期有效
更新 2013-08-13 11:02
 
詳細信息
廠家直銷CAS號:161796-78-7埃索美拉唑鈉
埃索美拉唑鈉

中文別名:埃索美拉唑鈉
CAS號:161796-78-7
分子量:369.41
分子式:C17H20N3NaO3S
埃索美拉唑鈉 
中文別名: 5-甲氧基-2-((S)-((4-甲氧基-3,5-二甲基-2-吡啶基)甲基)亞磺酰基
-1H-苯并咪唑鈉 
英文名稱: Esomeprazole sodium 
英文別名: 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)
sulfinyl-1H-benzimidazole sodium salt 
CAS號: 161796-78-7 
分子式: C17H20N3NaO3S 
分子量: 369.41
埃索美拉唑鈉

中文別名:埃索美拉唑鈉
CAS號:161796-78-7
分子量:369.41
分子式:C17H20N3NaO3S
埃索美拉唑鈉 
中文別名: 5-甲氧基-2-((S)-((4-甲氧基-3,5-二甲基-2-吡啶基)甲基)亞磺酰基
-1H-苯并咪唑鈉 
英文名稱: Esomeprazole sodium 
英文別名: 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)
sulfinyl-1H-benzimidazole sodium salt 
CAS號: 161796-78-7 
分子式: C17H20N3NaO3S 
分子量: 369.41
©2025 深圳石金谷科技有限公司 版權所有   技術支持:化工網   訪問量:29225  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |